APA (7th ed.) Citation

A, T., C, Z., C, R., M, B., C, F., J, G., . . . S, S. (2019). Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II trial (APREPRU). Acta dermato-venereologica, 99(4), 379. https://doi.org/10.2340/00015555-3120

Chicago Style (17th ed.) Citation

A, Tsianakas, et al. "Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II Trial (APREPRU)." Acta Dermato-venereologica 99, no. 4 (2019): 379. https://doi.org/10.2340/00015555-3120.

MLA (9th ed.) Citation

A, Tsianakas, et al. "Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II Trial (APREPRU)." Acta Dermato-venereologica, vol. 99, no. 4, 2019, p. 379, https://doi.org/10.2340/00015555-3120.